key: cord-0315725-ubhwo1w8
authors: Boskovic, F.; Zhu, J.; Tivony, R.; Ohmann, A.; Chen, K.; Alawami, M.; Djordjevic, M.; Ermann, N.; Pereira Dias, J.; Fairhead, M.; Howarth, M.; Baker, S.; Keyser, U. F.
title: Simultaneous identification of viruses and SARS-CoV-2 variants with programmable DNA nanobait
date: 2021-11-10
journal: nan
DOI: 10.1101/2021.11.05.21265890
sha: eb08a019bdb6036afeaaafbdf2877e66dceb1d6b
doc_id: 315725
cord_uid: ubhwo1w8

Respiratory infections are the major cause of death from infectious disease worldwide. The clinical presentation of many respiratory viruses is indistinguishable; therefore, diagnostic approaches that can identify multiple pathogens are essential for patient management. We aimed to address this challenge with self-assembled DNA nanobait that can simultaneously identify multiple short RNA targets. The nanobait approach relies on specific target selection via toehold-mediated strand displacement and rapid read-out via nanopore sensing. Here, we show this platform can concurrently identify several common respiratory viruses, detecting a panel of short targets of viral nucleic acids from SARS-CoV-2, respiratory syncytial virus (RSV), rhinovirus, influenza, and parainfluenza. Our nanobait could be reprogrammed to discriminate viral variants, and we identified several key SARS-CoV-2 variants with single-nucleotide resolution. We increased assay specificity with bespoke nanobait that could identify numerous short RNA targets in the same viral sample in a complex background of the human transcriptome. Notably, we found that the sequence position in the viral RNA secondary structure is critical for nanobait design. Lastly, we show that nanobait could discriminate between samples extracted from oropharyngeal swabs from negative and positive SARS-CoV-2 patients using programmable target cleavage without pre-amplification. Our system allows for multiplexed identification of native RNA molecules, providing a new scalable approach for diagnostics of multiple respiratory viruses in a single assay.

The diagnosis of infectious diseases plays a vital role in determining appropriate patient treatment 1 .

Respiratory tract infections are the major cause of death from infectious diseases globally 2,3 . Many respiratory viruses induce comparable symptoms and cannot be differentiated clinically, making the identification of appropriate treatment challenging. It is estimated that 65 % of infection-associated cases of pneumonia are potentially misdiagnosed, with 95 % of these cases erroneously receiving antimicrobials 4 . The ongoing COVID-19 pandemic further highlights another unmet diagnostic need: the routine identification and screening of viral variants as they arise 5 .

Currently, viral diagnostics rely on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), followed by genome sequencing to detect viral variants 5, 6 . PCR-based diagnostic methods provide a sensitive approach for detecting viral nucleic acids in complex biological samples but suffer from limited multiplexing capabilities 7 . There is a need for robust diagnostic methods that can simultaneously detect multiple respiratory viruses and variants in limited sample volume, which can be quickly reconfigured to detect additional variants as they arise. Newer nucleic acid detection methods, such as nanopore sensing, which can distinguish multiple nucleic acid species [8] [9] [10] [11] with a unique signature for each designed DNA nanostructure may be an alternative approach for multiplexed biosensing 19, 29, 30 . Various groups have shown that nanopore sensing after viral nucleic acid enrichment or amplification may be a suitable platform to challenge these diagnostics 10, 12, 13 .

Here, aiming to solve many of the limitations for diagnostic multiplexing, we developed an innovative method that employs bespoke nanobait for the simultaneous identification of multiple respiratory viruses and variants 14 . We employed programmable viral RNA cutting with RNase H to remove short RNA targets that uniquely identifies the virus. The resultant RNA target is captured by nanobait, which is detected instantaneously by nanopore sensing, without reverse transcription, pre-amplification, or purification. By multiplexing several targets from the same virus in samples containing human RNA, we . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint show that our method can increase specificity and throughput compared to existing platforms and paves the way for amplification-free RNA identification and diagnostics.

Patient samples were collected by swabbing the back of the throat (oropharyngeal swab) of patients as previously described 15 . The samples were collected from patients with the COVID-19-like clinical picture and were tested with the qRT-PCR after nucleic acid extraction. Briefly, after collection, swabs were placed into a labeled sample tube containing lysis buffer (4 M guanidine thiocyanate, 25 mM Tris-HCl, 0.5% β-mercaptoethanol, and MS2 RNA (Roche; 200 ng/µl)). The tube was gently agitated to ensure the even distribution of lysis buffer. The safety steps have been previously described and performed in a certified CL2 laboratory 15 .

Total nucleic acid was extracted using spin column-based systems and as employed by standardized qRT-PCR testing 15 . The internal amplification control (MS2 (~ 6 × 10 4 PFU/ml) per 10 ml of lysis buffer) was added in the top-up lysis buffer (25 µl per 10 ml of lysis buffer). The sample was eluted in 100 µl of nuclease-free water (nfH20, Invitrogen) and left to stand for 1 minute prior to centrifugation for 1 minute at 15,000 rpm in a benchtop microfuge. Eluted samples were directly subjected to qRT-PCR. The remaining nucleic acid extracts were stored at -80 °C and further used for nanobait-nanopore sensing.

SARS-CoV-2 detection was performed as previously described 15 . Per reaction, the master mix contained 12.5 µl of 2 × Luna Universal Probe One-Step reaction mix, 0.5 µl of 20 µM Wu forward primer (5'-ATGGGTTGGGATTATCCTAAATGTGA-3'), 0.5 µl of 20 µM Wu reverse primer (5'-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint GCAGTTGTGGCATCTCCTGATGAG-3'), 0.3 µl of 10 µM MGB Probe 3 FAM (5'-ATGCTTAGAATTATGGCCTCAC-3'), 0.5 µl of 10 µM of internal control forward primer for MS2 RNA, 0.5 µl of 10 µM internal control reverse primer for MS2 RNA, 0.3 µl of 10 µM internal probe (MS2 ROX), 1 µl of Luna WarmStart RT Enzyme Mix and 3.9 µl nfH20. 20 µl of the master mix was aliquoted into each well of a 96-well plate and then combined with 5 µl of each extract. The MS2 internal extraction and amplification control that underwent the full extraction protocol was included as the negative extraction control in a minimum of two wells on the qRT-PCR plate. To determine potential contamination in the qRT-PCR process, 5 µl nfH20 was included as the qRT-PCR negative control. 5 µl of spiked SARS-CoV-2 template plasmid was included in a single well as the qRT-PCR positive control.

After adding 5 µl of each sample to its designated well, the plate was sealed with an optically clear plastic seal. The plate was centrifuged for 1 min at 1,000 rpm at 4 °C and then inserted in the qRT-PCR machine (QuantStudio, Thermo Fisher Scientific) and the run was parametrized. Signals for fluorescein (FAM) and carboxyrhodamine (ROX) were acquired. ROX was used to detect the internal MS2 control and FAM was used to detect SARS-CoV-2 RNA. The assay was performed for 2 minutes at 25 °C, 15 minutes at 50 °C (for the reverse-transcriptase), 2 minutes at 90 °C, before 45 cycles of 95 °C for 3 seconds followed by 60 °C for 30 seconds. Results were determined by confirmation of the correct positive controls (amplification of the plasmid), the extraction and amplification controls of all samples (ROX channel), no amplification in the negative controls, and consistent mean values of controls. SARS-CoV-2 positivity was confirmed by amplification in the FAM channel with an appropriate sigmoidal curve with a cycle threshold (CT) value of ≤36. The CT values of MS2 and MGB probe 3 were maintained to track the quality and reproducibility of the assay 16 .

For nanopore sensing, nucleic acid extracts (patient samples) or MS2 viral RNA were used further for the detection with nanobait. Firstly, we mixed guide oligos with the sample and heated it to 70 °C for 5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint minutes. RNase H (5,000 units/ml, NEB) was added, mixed, and heated for 20 minutes at 37 °C to allow the enzyme to cut RNA in the DNA : RNA hybrid that effectively releases target RNA.

For the DNA nanobait designs, target sequences were selected to be in the conserved regions of a viral genome and had 40-60 % GC content to form a stable duplex. We tested all sequences for potential undesirable highly stable intramolecular interactions or homodimers using Nupack software 17 . Then we performed a cross-reactivity check between multiple sites employed in each experiment 17 .

We designed a DNA flower as another label for SARS-CoV-2 RNA detection from the patient samples.

Three DNA flowers specific for each SARS-CoV-2 target (7-way junctions, 7WJa, 7WJb, and 7WJc) were prepared separately. Taking 7WJc as an example, 4 μM DNA strand J1, J2, J3, and J4c is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint using Amicon® ultra 0.5 mL centrifugal filters with 100 kilodalton (kDa) cutoff with the washing buffer (10 mM Tris-HCl pH 8.0, 0.5 mM MgCl2). If DNA flowers were employed as a label, the partially complementary strands that carry it were incubated in 10 mM MgCl2 for 2 h at ambient temperature, and subsequently, Amicon filtration was performed as described above. The asymmetry of the nanobait design allows for unambiguous identification of the binding sites.

Nanobait was mixed with a sample (nucleic acid extract or purified viral targets) in 10 mM MgCl2 and 100 mM NaCl. The mixture (5 μL) was incubated at room temperature (~10 min) until prepared for nanopore measurement. We have used human total universal RNA (htRNA, Invitrogen) as a background where indicated, to show that there are no nonspecific signals induced by human native RNAs. For nanopore measurement, the sample was diluted to <0.5 nM nanobait (for purified viral targets) or 4.7 μL of RNase H cut patient sample was mixed with 0.3 μL of monovalent streptavidin (SAeID3) 19 (1 μM), 5 μL of LiCl (4 M), and 5 μL of LiCl (8 M). We have fabricated 14 ± 3 nm (mean ± s.d.) nanopores 18 using quartz glass capillaries with 0.5 mm outer diameter and 0.2 inner diameter (Sutter Instrument) by laserassisted puller P-2000 (Sutter Instrument). The mix was pipetted in a nanopore PDMS (polydimethylsiloxane) chip, and all measurements were performed at a constant voltage of 600 mV.

Nanopore measurement details are shown in Supplementary Table S29 .

Nanopore data analysis was explained in Supplementary section S13. Briefly, nanobait events were filtered out of raw ionic current traces, then the detection region was determined, and information of the spike's presence at each specific site was extracted. The displacement efficiency was calculated as a difference between a no target control and a measurement for each site (fifty nanobait events for each of three nanopore recordings). We verified that the convolutional neural network QuipuNet 20 was capable of real-time analysis of nanopore data following the described procedure.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint

Atomic Force Microscopy (Nanosurf Mobile S) imaging of nanobaits was performed in air in non-contact mode. nanobait structures were diluted to 1 ng/μL in 1 mM MgCl2 and 10 μL was added to freshly cleaved mica, incubated for 1 min, rinsed with filtered Milli-Q H2O, and then blow-dried with nitrogen.

Prior to scanning, the mica plate was affixed to the AFM sample stage using double-sided adhesive tape.

Image visualization and analysis were performed using Gwyddion.

99.9% confidence intervals for the displacement efficiencies were calculated for all measurements. The statistical significance between two sites without and with the target was tested using a student's T-test.

We developed a workflow for nanobait detection of target RNA, ranging from patient swabbing, nucleic acid extraction, and programmable RNase H cutting of viral RNA ( Figure 1 ). The RNA targets are selected by guide oligonucleotides (single-stranded DNA, 20 nt) that were designed to bind upstream and downstream on the specific regions in a viral genome. Then, RNase H was used to digest the RNA sequence in RNA: DNA hybrids (DNA guide oligo hybridized to viral RNA segment) and release the middle target RNA (Figure 1a , right).

Released RNA targets were identified using sequence specific binding to the nanobait (Figure 1b-c) . The nanobait was designed (more details in Supplementary Figure S1 ) with five binding sites that could incorporate up to five targets. Nanobait was assembled by mixing a single-stranded DNA scaffold (linearized M13mp18, 7228 nt long) 18 with a collection of short complementary oligonucleotides ( Figure   1b and Supplementary Table S2 ). Towards one end of the nanobait, the sensing region was designed to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint contain equally spaced sites a-e flanked by two reference structures R1 and R2, which consisted of six DNA dumbbells each (oligonucleotides are listed in Supplementary Table S3 ). The sensing site contained a DNA overhang, which was fully complementary to the respective target sequence. We additionally exploited a blocking oligo with a label (monovalent streptavidin or DNA flower; Supplementary Figure   S2 and Table S1 ) that was only partially hybridized and left six bases unpaired. Assembly of the nanobait was confirmed by AFM imaging and an electrophoretic mobility shift assay (EMSA) (Supplementary Figure   1d ), the five labeled oligos were displaced and only the reference spikes remain (Figure 1g ). The short duplexes were significantly smaller than the labels and not detected with these nanopores 18 . Each ionic current event on a single nanobait revealed the presence of multiple short RNA targets. The flexibility of the nanobait design permitted us to identify targets originating from multiple parts of the same virus or from multiple viral genomes.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint using programmable RNase H cutting. Such treated sample was further tested for viral presence. b) Nanobait is made by mixing a single-stranded DNA scaffold (M13mp18 DNA) with short oligonucleotides where some of them carry complementary capture strands (a-e) for specific targets (a'e') in a target viral RNA. In addition, a partially complementary oligo with a structural label (protein or DNA-based, white square) is added for each site to amplify the signal in nanopore recordings. We marked a sensing region with two references (dark gray). Nanobait before c) and after d) strand displacement reactions of five targets (colored strands). If targets are present the five gray strands with labels are displaced. Two outer signals originate from reference structures that indicate the sensing region, and the five binding sites between the references are specific for the five different targets. e) Each nanobait is voltage-driven through the nanopore and detected in a complex mixture of molecules. f) Typical nanopore current signature as a function of time for a nanobait as designed with five labels present. The first current drop corresponds to DNA (ΔIDNA) and the second to labels (ΔIlabel). g) Typical nanobait event after strand displacement of all five targets. The presence of the targets is detected by the missing downward signals specific to each target.

We designed nanobait for the multiplexed target identification of SARS-CoV-2, RSV (universal for group A), rhinovirus (universal), influenza (universal for group A), and parainfluenza 1 (Supporting information   Table S4 -S7). A schematical design of the nanobait for multiple respiratory viral nucleic acid targets is shown in Figure 2a . RSV is provided as an example of site-specific displacement (Figure 2a) . The five targets, as well as the control (no target), were detected independently using the same nanobait. The first nanopore translocation events of the nanobait in each of the individual samples are depicted in Figure 2a and Supplementary Figure S6 . Nanopore events with seven spikes indicated the absence of targets. If the respective target for SARS-CoV-2, RSV, rhinovirus, influenza, or parainfluenza were present, that spike . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint was absent in the nanobait translocation event (presence of the targets are shown in Supplementary Table   S4 ). The displacement efficiency was calculated as the difference between a no target control and the measurement for each site (fifty nanobait events for each of three nanopore recordings) (p<0.001; student's T test). (Figure 2c) . We tested two different scenarios, with and without targets for statistical significance.

Variant discrimination with single-nucleotide resolution is an essential feature for variant diagnostics. We tested the potential of nanobait for single nucleotide variant (SNV) discrimination, by distinguishing nucleic acids from several SARS-CoV-2 variants. The five sites of nanobait allowed for the simultaneous detection of wild-type virus and four variants (sequences are listed in Table 8 Table S11 ). The displacement efficiency is dependent on the number and position of mismatches in the toehold domain 24 . Programming nanobait with a singlenucleotide mismatch allowed us to discriminate the SARS-CoV-2 variant from the WT sequence. We depict example events for each sample where all spikes are present (no targets) or the respective spike is absent depending on which variant is present (Figure 2b ; more events are shown in Supplementary Figure   S7 ; presence of the targets are shown in Supplementary Table S8 ). Figure 2d shows the displacement efficiency for WT targets and their corresponding variant targets for the first fifty nanobait events (colored bars). We observed a significant difference for all four variants when compared to the respective WT samples (light and dark-colored bars).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint 

Diagnostic tests for viral RNA rely on multistep reactions and subsequent purification steps. We aimed to use nanobait for direct target identification without preamplification and purification. Here, we used nanobait for specific single-molecule detection in a complex human transcriptome mixture i.e. human total universal RNA (htRNA; Invitrogen). These nanobait could identify multiple samples from pooled samples in complex backgrounds by nanopore sensing (Figure 3a) .

We pooled five synthesized SARS-CoV-2 RNA targets together to investigate the specificity and potential crosstalk between nanobait and non-specific htRNA background. After the targets were added, all sites were displaced and correctly identified using the nanopore measurements (Figure 3b ). A typical current trace indicates that nanobait spikes can be easily distinguished (red boxes, Figure 3c ) from nonspecific current blockages originating from the htRNA. Figures 3d and 3e show the first five linear nanobait events for samples with and without targets and in the presence of htRNA; the displacement efficiency for all five targets is depicted in Figure 3f . Target 4 had the lowest displacement efficiency, which was in agreement with a low predicted GC content of 25 % 25 . Nanobait based strand displacement can operate effectively even in a complex background of htRNA, oligonucleotides, and proteins. We studied the kinetic details for both RNA and DNA targets and determined that 10 minutes was the optimal . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint incubation time for the strand displacement reaction (corresponding plots and events are presented in Supplementary section S8; presence of the targets are shown in Supplementary Table S13; target sequences and oligonucleotides are listed in Tables S14-S16). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint be identified in parallel as shown in the example events. c) Ionic current traces indicate the specificity of the method for the identification of nanobait-specific events even in a complex background where large downward signals originate from background including long RNAs. All nanobait events have been highlighted in red dashed boxes. d) First five single-file nanobait events for sample mixed with only human total RNA indicate correct current signature. e) The first five single-file nanobait events that have been previously mixed with targets and human total RNA. All targets are present since corresponding spikes are absent in nanopore events. f) Displacement efficiency calculated for the sample with targets added (nanobait with targets and human total RNA) for all five sites. Error bars represent standard error for three nanopore measurements and fifty nanopore events per measurement.

We next aimed to optimize multiple parameters in designing an efficient target RNA identification system. One key parameter was the successful excision of the short RNA targets from viral RNA. We found that the location of the target RNA in the viral RNA secondary structure affected the concentration of free target RNA and consequently affected displacement efficiency. A target in a highly complementary region would remain bound to the viral RNA after cutting and prevent detection. In contrast, the release of the target after RNase H excision increases when more unpaired bases were in the target region than within the secondary structure of the viral RNA. For future experiments, we maximized the number of unpaired bases to increase the effective concentration of the target in solution and consequently aid detection.

The role of unpaired bases was demonstrated by the detection of three targets in ~3.6 kb RNA genome of MS2 virus (Figure 4a , the minimal free energy secondary structure 26 ). The three targets (T1, T2, and T3) had a decreasing percentage of unpaired bases (T1 -55%, T2 -30%, and T3 -25%). Subsequently, we designed oligos and employed RNase H cutting of all three targets and quantified the displacement . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint efficiency using nanobait with the three sites (Figure 4b , more events are shown in Supplementary Figure   S14 ; presence of the targets are shown in Supplementary Table S17; oligonucleotides are listed in   Supplementary Tables S18-S22 ). Efficient cutting of viral RNA was confirmed by agarose gel electrophoresis (Supplementary Figure S10) . For each target, the original 3.6 kb RNA was cut in fragments of the predicted length; additionally, the predicted fragment lengths were comparable when all three targets were cut simultaneously. We confirmed that target T1 was free in solution by hybridizing it to the complementary capture strand C and detected it using polyacrylamide gel electrophoresis (PAGE) (Figure 4c ). After cutting, target T2 was not visible by PAGE (Supplementary Figure S13) , and the oligonucleotides running speed and non-specific interactions were validated on a control PAGE (Supplementary Figure S11 and S12).

Example nanopore events and displacement efficiency with and without targets released from the MS2 RNA genome after RNase H cutting are shown in Figures 4b and 4d . The plot indicates that displacement was detected for all three targets. Target T1 had the highest displacement efficiency, while target T3 had the lowest displacement efficiency. As predicted, displacement efficiency ( Figure 4d ) correlated with unpaired base percentage in the RNA structure for each target, signifying an important design principle in selecting viral target regions for detection.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint Displacement efficiency of target RNAs correlates with the percentage of unpaired bases in a target. T1 has shown the highest displacement while T2 and T3 have lower displacement efficiencies. Error bars represent standard error for three nanopore measurements and fifty nanopore events per measurement.

After establishing that RNase H had cut the MS2 RNA, we considered that nanobait could detect SARS-CoV-2 RNA in clinical samples. We accessed oropharyngeal swabs from patients suspected to have COVID-19; the viral load SARS-CoV-2 in oropharyngeal swabs in the clinical phase is 10 8 -10 11 copies 27 . We used nanobait in nucleic acid extractions from clinical samples that had been prepared for qRT-PCR (more details in Supplementary section S11; oligos are listed in Supplementary Tables S23-S26) 15 . SARS-CoV-2 targets (S1, S2, and S3) were designed in conserved regions of the genome that contained the highest percentage of unpaired bases (Figure 5a ). S1 was in the region encoding the spike (S) protein, S2 was in the region encoding the small envelope (E) glycoprotein, and S3 was in the nucleocapsid (N) protein-coding region. Total nucleic acids from clinical samples were subjected to our RNase H protocol ( Figure 5b ) and then mixed with a nanobait with sensing sites S1, S2, and S3. The reaction did not require further purification or preamplification before the nanopore readout. The nanobait mixture was then analyzed with nanopores containing the complex background of DNA (human and optionally DNA flower), long RNAs (human and potentially viral), short guide oligos, and proteins (RNase H and monovalent streptavidin).

Nanopore events from the nanobait mixed with RNase H treated negative patient samples (confirmed with qRT-PCR) are shown in Figure 5c . In addition to the two reference spikes (dark gray), three further spikes were visible and corresponded with sites for S1 (blue), S2 (green), and S3 (orange). As shown above, the nanobait current signature was not affected by the complex background or unspecific binding of DNA guide oligos. The missing spike associated with specific displacement was apparent when the nanobait . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We additionally exploited a DNA flower as an alternative to a monovalent streptavidin. We observed comparable results with this DNA-based system (more details in Supplementary section S12), indicating that the detection system can be based only on DNA. An all-DNA nanobait system may aid future upscaling.

Our nanobait approach bypasses pre-amplification and purification and hence avoids these potentially time-consuming and expensive steps. Furthermore, the nanopore readout time can be further reduced by performing real-time analysis on the QuipuNet convolutional neural network 20 . QuipuNet has high accuracy with an analysis speed of 1,600 events/s, which is more than sufficient for rapid viral detection (~10 min).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint enabling rapid nanopore readout (~10 min). Example events for both negative and positive SARS-CoV-2 samples were presented in c) and d), respectively. e) The displacement efficiency in a negative sample differs from positive samples for ten repeats. Error bars indicate standard error for all events in the first ten minutes. Difference between negative and positive samples has statistical significance (p < 0.001; student's T test).

Here, we demonstrate the site-specific excision of a target from long viral RNA using RNase H cutting. In this way, we increase the displacement efficiency by ensuring the exact target sequence for displacement reaction in comparison to non-specific RNA fragmentation 28 . Additionally, site-specific RNA cutting can be achieved using DNAzymes or even CRISPR/Cas system 29, 30 .

Previous nanopore studies have demonstrated the ability to detect one or a limited number of short nucleic acid species in isolated form 10, 12, 28, [31] [32] [33] . However, the real challenge is the biological complexity within a test sample and discriminating targets in this complex background 11, 34 . Our work demonstrates that DNA nanotechnology can be used to detect specific targets in complex clinical samples with nanopores. As a proof of concept, we tested nanobait against five different respiratory viruses or SARS-CoV-2 variants in parallel. Previously, we showed that with DNA encoding a library of 2 112 molecules with the potential to test for 100s and 1000s of viral targets in parallel can be created 18, 35 , especially when multiplexed nanopore systems become more advanced.

Recent studies have developed a viral nucleic acid detection system using nanopores which holds great promise for a rapid detection system 10, 12, 13, 36 . However, preamplification and enzymatic steps in preparation for nanopore detection limit the utility of such methods. Our nanobait system does not necessitate preamplification and can identify native RNA sequences without the need for sequencing. The design of this approach overcomes an issue of non-specific spikes in nanopore measurements by using the absence of a downward spike as a positive signal for identification of the presence of the target sequence.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint Nanobait can also identify multiple targets from the same viral RNA, hence offering enhanced specificity and accuracy for viral identification, as we demonstrated for the detection of SARS-CoV-2 in clinical specimens.

Rapid programmability of diagnostic platforms is of paramount importance for detecting new viruses or their variants as they arise 14 . Our nanobait is rapidly adaptable for new viral targets, as we demonstrated by discriminating the emerging SARS-CoV-2 variants. Our study has the potential for amplification-free native RNA identification. Nanobait bypasses amplification sequence biases by detecting innate RNA diversity. Our results show that nanobait identify short and long RNAs and may find wider applications in analysis of physiological and pathological conditions including cancer detection.

In conclusion, we have demonstrated the simultaneous identification of nucleic acids from multiple viruses and SARS-CoV-2 variants in a specific and rapid approach by combining DNA nanotechnology and nanopore sensing. We employed the easily programmable nanobait with strand displacement for the discrimination of SARS-CoV-2 WT RNA from variant RNA, including three variants of epidemiological concern 14 . Finally, we successfully used the nanobait-based nanopore sensing method in clinical samples and could accurately discriminate SARS-CoV-2 negative from positive patient swabs with ~10 min nanopore readout. Nanobait avoids reverse transcription, amplification, or reaction purification, therefore, bypassing enzymatic biases and some additional steps. As nanobait has proven to be specific and accurate for viral detection in patient samples, we think our platform can be employed for native RNA detection.

Nanobait paves a way for a multiplexed amplification-free RNA detection method that is dependent only on the rapid single-molecule readout of nanobait structure.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2021. ; https://doi.org/10.1101/2021.11.05.21265890 doi: medRxiv preprint

Better tests, better care: improved diagnostics for infectious diseases

The economic cost of respiratory disease in the UK. The Lancet Respiratory

Transmissibility and transmission of respiratory viruses

Adults miscoded and misdiagnosed as having pneumonia: results from the British Thoracic Society pneumonia audit

Methods for the detection and identification of SARS-CoV-2 variants. World Health Organization. Regional Office for

Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection

Multiplex PCR and emerging technologies for the detection of respiratory pathogens

Label-Free Optical detection of DNA translocations through plasmonic nanopores

Label-free optical detection of biomolecular translocation through nanopore arrays

Quantification of mRNA expression using single-molecule nanopore sensing

Direct electrical quantification of glucose and asparagine from bodily fluids using nanopores

Direct detection of conserved viral sequences and other nucleic acid motifs with solid-state nanopores

Programmable DNA nanoswitch sensing with solid-state nanopores

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities

Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection

Constrained multistate sequence design for nucleic acid reaction pathway engineering

Digitally encoded DNA nanostructures for multiplexed, single-molecule protein sensing with nanopores

Plug-and-play pairing via defined divalent streptavidins

Convolutional neural network for single-molecule nanopore sensing

Specific biosensing using DNA aptamers and nanopores

Solid-state nanopores

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Single molecule based SNP detection using designed DNA carriers and solid-state nanopores

Rational siRNA design for RNA interference

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information

Virological assessment of hospitalized patients with COVID-2019

Programmable low-cost DNA-based platform for viral RNA detection

A biologically stable DNAzyme that efficiently silences gene expression in cells

Programmable RNA recognition and cleavage by CRISPR/Cas9

Aerolysin nanopores decode digital information stored in tailored macromolecular analytes

Rapid electronic detection of probe-specific microRNAs using thin nanopore sensors

Analysis of single nucleic acid molecules with protein nanopores

Rational design of DNA nanostructures for single molecule biosensing

Digital Data Storage Using DNA nanostructures and solid-state nanopores

Nanopore microscope identifies RNA isoforms with structural colors

We thank Tim Fitzmaurice for his operational help during the COVID-19 pandemic. We acknowledge the Statistics Clinic, Centre for Mathematical Sciences for their guidelines on a statistical analysis of data presented in this study. Funding

acknowledges funding from George and Lilian Schiff Foundation Studentship, the Winton Programme for the Physics of Sustainability Ph.D. Scholarship, and St John's College Benefactors' Scholarship. A.O. acknowledges funding from the Cambridge Trust Vice Chancellor's Award. R.T. acknowledges funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 892333

Blavatnik Family Foundation. M.F.A. acknowledges funding from UKSCAB scholarship. N.E. acknowledges funding from the EPSRC, Cambridge Trust, and Trinity Hall, Cambridge. M.F. and M.H